Bottom line
What does IBRN hold?
IBRN held 78 positions as of Jul 31, 2026. Its largest holding is BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares at 14.64% of the fund, and the top 10 positions add up to 56.2%. By asset type it is 96% stocks, 15% cash & short-term funds, 4% other.
Updated Sep 23, 2026
IBRN top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY |
Cash & short-term funds | 14.64% | $802.9K |
| 2 | Dianthus Therapeutics Inc DIANTHUS THERAPEUTICS INC |
Stocks | 5.34% | $292.9K |
| 3 | Xenon Pharmaceuticals Inc XENON PHARMACEUTICALS INC |
Stocks | 4.87% | $267.2K |
| 4 | Praxis Precision Medicines Inc PRAXIS PRECISION MEDICINES INC |
Stocks | 4.87% | $267.2K |
| 5 | Acadia Pharmaceuticals Inc. ACADIA PHARMACEUTICALS INC |
Stocks | 4.69% | $257.4K |
| 6 | Arrowhead Pharmaceuticals, Inc. ARROWHEAD PHARMACEUTICALS INC |
Stocks | 4.65% | $255.3K |
| 7 | Alkermes Public Limited Company ALKERMES PLC |
Stocks | 4.60% | $252.4K |
| 8 | Scholar Rock Holding Corp SCHOLAR ROCK HOLDING CORP |
Stocks | 4.29% | $235.5K |
| 9 | Biogen Inc. BIOGEN INC |
Stocks | 4.18% | $229.1K |
| 10 | Neurocrine Biosciences, Inc. NEUROCRINE BIOSCIENCES INC |
Stocks | 4.09% | $224.3K |
| 11 | argenx SE ARGENX SE |
Other | 3.86% | $211.7K |
| 12 | Ptc Therapeutics, Inc. PTC THERAPEUTICS INC |
Stocks | 3.85% | $211.4K |
| 13 | Axsome Therapeutics, Inc. AXSOME THERAPEUTICS INC |
Stocks | 3.77% | $206.9K |
| 14 | Denali Therapeutics Inc DENALI THERAPEUTICS INC |
Stocks | 3.67% | $201.4K |
| 15 | Dyne Therapeutics, Inc DYNE THERAPEUTICS INC |
Stocks | 3.56% | $195.5K |
| 16 | Edgewise Therapeutics Inc EDGEWISE THERAPEUTICS INC |
Stocks | 3.23% | $177.4K |
| 17 | Supernus Pharmaceuticals, Inc. SUPERNUS PHARMACEUTICALS INC |
Stocks | 2.61% | $142.9K |
| 18 | AxoGen, Inc. AXOGEN INC |
Stocks | 2.34% | $128.4K |
| 19 | SK Biopharmaceuticals Co Ltd SK BIOPHARMACEUTICALS CO LTD |
Stocks | 2.30% | $126.1K |
| 20 | H. Lundbeck A/s H LUNDBECK A S |
Stocks | 1.84% | $100.8K |
| 21 | Biohaven Ltd BIOHAVEN LTD |
Stocks | 1.82% | $99.6K |
| 22 | Sarepta Therapeutics, Inc. SAREPTA THERAPEUTICS INC |
Stocks | 1.61% | $88.5K |
| 23 | BioArctic AB BIOARCTIC AB |
Stocks | 1.56% | $85.6K |
| 24 | Taysha Gene Therapies Inc TAYSHA GENE THERAPIES INC |
Stocks | 1.50% | $82.0K |
| 25 | Neuren Pharmaceuticals Ltd NEUREN PHARMACEUTICALS LTD |
Stocks | 1.48% | $81.1K |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026